RESUMEN
OBJECTIVE: Management of patients with dyspepsia remains controversial. No consensus has yet been reached concerning diagnostic and medical strategies. We conducted a randomized trial to assess the effectiveness of three management strategies for patients with uninvestigated persistent dyspeptic symptoms. METHODS: A total of 199 patients presenting in primary care with dyspeptic symptoms (age 18-65 years, no alarming symptoms) were randomized to either empirical treatment with omeprazole and, in the case of symptomatic relapse, serological Helicobacter pylori infection testing plus eradication therapy (treat-and-test group), prompt upper gastrointestinal endoscopy (endoscopy group) or prompt upper gastrointestinal radiography (radiography group) followed by directed medical treatment. Symptoms, patients' satisfaction and use of resources were recorded during 6 months of follow-up. RESULTS: Sixty-nine patients were assigned to the treat-and-test group, 64 to the radiography group and 66 to the endoscopy group. The median age was 44 years; 104 patients were male and 37% were H.pylori infected. A total of 170 patients (85%) returned the 6 months questionnaire. The numbers of patients with complete symptom relief in the treat-and-test group, endoscopy group and radiography group were 21, 16 and 15, respectively, at 3 months (P = 0.59), and 23, 13 and 12, respectively, at 6 months (P = 0.05). Twenty-two patients in the treat-and-test group underwent endoscopy or radiography. Two patients in the endoscopy group and four patients in the radiography group underwent more than one diagnostic test. The average medical cost per patient for the treat-and-test group was euro 276, for the endoscopy group euro 426 and for the radiography group euro 321, respectively. CONCLUSION: Empirical treatment followed by a test-and-eradicate strategy resulted in fewer diagnostic tests, more symptom relief and lower medical costs compared with prompt upper gastrointestinal radiography or endoscopy in the management of uninvestigated patients with persistent dyspeptic symptoms.
Asunto(s)
Antiulcerosos/uso terapéutico , Dispepsia/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Omeprazol/uso terapéutico , Adulto , Dispepsia/diagnóstico por imagen , Dispepsia/economía , Femenino , Gastroscopía/economía , Infecciones por Helicobacter/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Países Bajos , Radiografía , Resultado del TratamientoRESUMEN
Recently, The Netherlands Society of Gastroenterohepatology (Nederlands Genootschap Maag-Darm-Leverartsen; NGMDL) and the Netherlands Association of Internal Medicine (Nederlandse Internisten Vereniging; NIV) set up a covenant to optimise the collaboration between internists and gastroenterologists. Important points: certification of endoscopic skills; training of residents of internal medicine with regard to pathology of the stomach, intestines and liver as well as to endoscopy, and the training in internal medicine of residents in gastroenterology; defining competence of gastroenterologists for night and weekend duties in internal medicine.
Asunto(s)
Gastroenterología/organización & administración , Medicina Interna/organización & administración , Humanos , Países BajosRESUMEN
Helicobacter pylori serology and in particular enzyme-linked immunosorbent assays for the measurement of immunoglobulin G (IgG) antibody titers form an accurate means of diagnosing H. pylori infection in patients before treatment. H. pylori serology is of limited value in monitoring treatment because of the slow decline in antibody titers. In the present study we aimed to measure the most suitable moment after antibiotic treatment at which serology should be used to monitor treatment. Sixty-four patients who had nonulcer dyspepsia and H. pylori infection and who underwent upper gastrointestinal endoscopy because of persistent dyspeptic symptoms were included in the study. H. pylori cure was confirmed by histology and culture 5 weeks after the completion of the antibiotic treatment. Serological examination was performed before therapy and at 5 weeks, 10 weeks, and 1 year after the completion of antibiotic treatment. Diagnostic performance was assessed by receiver-operating characteristic analysis. The areas under the receiver-operating characteristic curves of the H. pylori antibody titers at 5 weeks, 10 weeks, and 1 year after the completion of treatment were 0.53 (95% confidence interval [CI], 0.36 to 0.69), 0.60 (95% CI, 0.43 to 0.76), and 0.78 (95% CI, 0.63 to 0.93), respectively. The areas under the receiver-operating characteristic curves of the changes in H. pylori IgG antibody titers at 5 weeks, 10 weeks, and 1 year after the completion of treatment in comparison with the pretreatment titers were 0.85 (95% CI, 0.72 to 0.97), 0.96 (95% CI, 0.89 to 1.0), and 1.0 (95% CI, not estimable), respectively. We conclude that serology forms a useful means of monitoring treatment in patients with nonulcer dyspepsia and H. pylori infection as early as 10 weeks and maybe even sooner after the completion of treatment for the infection.
Asunto(s)
Antibacterianos/uso terapéutico , Anticuerpos Antibacterianos/análisis , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/inmunología , Inmunoglobulina G/análisis , Especificidad de Anticuerpos , Biomarcadores , Estudios de Seguimiento , Infecciones por Helicobacter/inmunología , Helicobacter pylori/efectos de los fármacos , Humanos , Evaluación de Resultado en la Atención de Salud , Curva ROC , Resultado del TratamientoRESUMEN
A large hepatocellular adenoma was diagnosed in a female patient who was referred for severe upper abdominal pain. She had been using oral contraceptives over a period of 14 years. The clinical features, diagnosis and treatment are discussed.
Asunto(s)
Dolor Abdominal/etiología , Adenoma de Células Hepáticas/complicaciones , Neoplasias Hepáticas/complicaciones , Dolor Abdominal/diagnóstico , Dolor Abdominal/cirugía , Adenoma de Células Hepáticas/diagnóstico , Adenoma de Células Hepáticas/cirugía , Adulto , Anticonceptivos Orales , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/cirugía , Tomografía Computarizada por Rayos XRESUMEN
AIMS: To investigate the effect of eradication of Helicobacter pylori infection on gastric epithelial damage and gastritis, scored according to the Sydney system. METHODS: Gastritis scores and epithelial damage were assessed in gastric biopsy specimens before, and five weeks and one year after anti-H pylori therapy in 66 patients with H pylori related gastritis. RESULTS: The mean initial levels of activity, inflammation, atrophy, intestinal metaplasia, and H pylori scores were higher in the antrum than in the corpus or fundus. Eradication of H pylori resulted in an improvement in the mean inflammatory score in antral biopsy specimens from 2.23 before treatment to 1.32 and 1.06, respectively, five weeks and one year after treatment. Corresponding values for fundic biopsy specimens were 1.30, 0.36 and 0.35. Activity scores improved from 1.41 before treatment to 0.13 and zero, respectively, five weeks and one year after treatment in antral biopsy specimens and from 0.60 before treatment to zero in fundic biopsy specimens. Before treatment, epithelial damage was present in 51% of biopsy specimens taken from the antrum and 23% of those from the corpus. Five weeks after eradication of H pylori none of the biopsy specimens revealed evidence of epithelial damage. CONCLUSION: Eradication of H pylori is followed by a rapid, significant improvement in the gastritis score and resolution of epithelial damage in antral and fundic mucosa.
Asunto(s)
Gastritis/microbiología , Gastritis/patología , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Atrofia/patología , Epitelio/patología , Estudios de Seguimiento , Fundus Gástrico/patología , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Metaplasia/patología , Antro Pilórico/patologíaRESUMEN
BACKGROUND: Helicobacter pylori infection of the antral mucosa is responsible for an increase in basal and stimulated serum gastrin. In the present study we have investigated whether gastritis induced by H. pylori is responsible for abnormalities in the processing of gastrin in dyspeptic patients. METHODS: Basal serum gastrin was measured by radioimmunoassay before, 5 weeks, and 1 year after anti-H. pylori therapy in 73 H. pylori positive functional dyspeptic patients. Three region-specific antisera were used, specific for the biologically active carboxy-terminal part, the biologically inactive amino-terminal part of gastrin 1-17, and for the non-sulphated tyrosyl residue in gastrin 1-17. RESULTS: Basal serum gastrin levels were markedly (P < 0.01) decreased 5 weeks and 1 year after successful eradication of H. pylori (n = 39) but not in the patients in whom treatment failed (n = 34). A decline of gastrin was observed for each of the three radioimmunoassays. CONCLUSION: The decrease of serum gastrin levels in all three radioimmunoassays after a successful eradication of H. pylori does not point to major changes in the processing of gastrin. These results suggest that G-cells in the antral mucosa are not functionally affected by the inflammation.
Asunto(s)
Gastrinas/sangre , Gastritis/sangre , Infecciones por Helicobacter/sangre , Helicobacter pylori , Adulto , Anciano , Cromatografía/métodos , Dextranos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Radioinmunoensayo , Sensibilidad y Especificidad , Factores de TiempoRESUMEN
Thirty-three dyspeptic patients with colonization of Helicobacter pylori in the gastric antrum were treated with tripotassium dicitrate bismuthate 120 mg q.d.s. for 28 days and metronidazole 250 mg q.d.s. for 10 days starting on day 19. Five weeks after cessation of this treatment regimen H. pylori was eradicated in 23 patients. In 8 of the remaining 10 patients, H. pylori had become resistant to metronidazole. In this study resistance was significantly associated with smoking habits, but not with age, bacterial load, gastritis score or alcohol consumption.
Asunto(s)
Gastritis/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Metronidazol/uso terapéutico , Fumar , Adulto , Anciano , Farmacorresistencia Microbiana , Femenino , Gastritis/microbiología , Humanos , Masculino , Metronidazol/administración & dosificación , Metronidazol/farmacología , Persona de Mediana EdadRESUMEN
A young male patient was referred for endoscopic resection of a recto-sigmoid polyp and abdominal complaints. His medical history revealed a sebaceous adenoma resection from his back and a tubular adenoma excision from his right upper eyelid. After disclosure of a jejunal tumour on a small bowel enema and given the remarkable family history characterized by the frequent occurrence of bowel cancer, the diagnosis of Muir-Torre syndrome was established. This syndrome pertains to the combination of sebaceous gland tumours/adenomas in combination with gastrointestinal or genitourinary tract tumours. Inheritance takes place in an autosomal dominant manner. It usually occurs in males at an early age. Given its low malignancy potential, early detection of the syndrome renders a favourable prognosis. Careful examination and follow-up also involving the small intestine are mandatory for patients and relatives.
Asunto(s)
Adenocarcinoma , Adenoma , Obstrucción Intestinal/etiología , Neoplasias del Yeyuno , Neoplasias Primarias Múltiples , Neoplasias de las Glándulas Sebáceas , Adenocarcinoma/complicaciones , Adenocarcinoma/diagnóstico por imagen , Adenocarcinoma/genética , Adenocarcinoma/patología , Adenocarcinoma/cirugía , Adenoma/genética , Adenoma/cirugía , Adulto , Sulfato de Bario , Colonoscopía , Enema , Humanos , Neoplasias del Yeyuno/complicaciones , Neoplasias del Yeyuno/diagnóstico por imagen , Neoplasias del Yeyuno/genética , Neoplasias del Yeyuno/patología , Neoplasias del Yeyuno/cirugía , Masculino , Neoplasias Primarias Múltiples/complicaciones , Neoplasias Primarias Múltiples/diagnóstico por imagen , Neoplasias Primarias Múltiples/genética , Neoplasias Primarias Múltiples/patología , Neoplasias Primarias Múltiples/cirugía , Radiografía , Neoplasias de las Glándulas Sebáceas/genética , Neoplasias de las Glándulas Sebáceas/cirugía , SíndromeRESUMEN
A patient known with acute intermittent porphyria who developed primary liver-cell carcinoma is described. No other risk factors were found. A possible association of acute intermittent porphyria with the development of primary liver-cell carcinoma has been suggested in recent, mainly Scandinavian literature. So far this association has never been described in The Netherlands.
Asunto(s)
Carcinoma Hepatocelular/etiología , Hepatopatías/complicaciones , Neoplasias Hepáticas/etiología , Porfirias/complicaciones , Enfermedad Aguda , Anciano , Humanos , MasculinoRESUMEN
During 1968-1988 one endoscopist performed 3154 endoscopic examinations of the upper gastrointestinal tract and detected 400 (13%) malignancies. Endoscopy was indicated in persisting dyspepsia or abnormal findings on X-ray examination of the stomach. In 242 patients earlier subjected to partial gastrectomy 7% stomach cancers were found. No difference existed in the incidence of stomach cancer between patients with either BI and BII gastrectomy. Initially no malignancy was detected in 9 (2.3%) patients. The maximum diagnostic delay was 5 months in these patients. This finding underlines the necessity of a strict follow-up scheme when studying malignancies.
Asunto(s)
Neoplasias Esofágicas/diagnóstico , Neoplasias Gástricas/diagnóstico , Anciano , Neoplasias Esofágicas/diagnóstico por imagen , Gastrectomía/métodos , Gastroscopía , Humanos , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico , Radiografía , Estudios Retrospectivos , Estómago/diagnóstico por imagen , Neoplasias Gástricas/diagnóstico por imagen , Factores de TiempoAsunto(s)
Campylobacter/efectos de los fármacos , Metronidazol/farmacología , Adulto , Anciano , Infecciones por Campylobacter/tratamiento farmacológico , Farmacorresistencia Microbiana , Femenino , Gastritis/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Factores Sexuales , Úlcera Gástrica/tratamiento farmacológicoRESUMEN
Chronic pancreatitis, often with a pseudocyst, is a rare cause of a pleural exudate. A pancreatic pleural fistula is created, leading to a relapsing massive haemorrhagic pleural exudate with a very high amylase content. The diagnosis is confirmed by means of endoscopic retrograde pancreatography. Treatment is primarily conservative; surgical drainage is sometimes necessary. The prognosis is generally favourable. The case history of a young woman with this condition is presented.
Asunto(s)
Pancreatitis/complicaciones , Derrame Pleural/etiología , Adulto , Amilasas/análisis , Enfermedad Crónica , Drenaje , Femenino , Humanos , Seudoquiste Pancreático/complicaciones , Pancreatitis/terapia , Derrame Pleural/terapiaRESUMEN
Detection of liver cell membrane autoantibodies is routinely performed by immunofluorescence testing of patient sera on rabbit hepatocyte suspensions. We have investigated the possible use of cells from the PLC/PRF/5 human hepatoma cell-line. These cells were employed as substrate in an immunofluorescence test which was compared with the conventional rabbit hepatocyte assay. We found a close correlation between the results obtained with these different substrates on visual reading. We furthermore compared visual reading of immunofluorescence preparations with flow-cytometrical analysis of immunostained cell suspensions. The results with these different methods were largely confirmatory. The PLC/PRF/5 cells are easily available and should therefore be regarded as a highly valuable new substrate for detection of liver cell membrane autoantibodies. Flow cytometry appears to be a technically simple and reliable method for quantitative analysis.
Asunto(s)
Autoanticuerpos/análisis , Carcinoma Hepatocelular/inmunología , Hepatitis/inmunología , Neoplasias Hepáticas/inmunología , Hígado/inmunología , Animales , Especificidad de Anticuerpos , Autoanticuerpos/inmunología , Línea Celular , Membrana Celular/inmunología , Enfermedad Crónica , Técnica del Anticuerpo Fluorescente , Humanos , ConejosRESUMEN
We have defined some membrane antigens of the cultured hepatocellular carcinoma cell line PLC/PRF/5, which contains the integrated genome of hepatitis B virus. Using fluoresceinated antibodies, we identified HLA Class 1 glycoprotein and HB surface antigen on the membrane. Only in a minority of cells was physical association of these antigens demonstrated by co-capping. The presence of a "division" antigen was indicated by reactivity of the cells with the murine monoclonal antibody OKT9.